John J. Spinelli

Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

Laurie H. Sehn, Jane Donaldson, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2005 · 989 citations · Full text

Medicine, Hematology, Oncology +8

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium

Karin E. Smedby, Claire M. Vajdic, Michael O. Falster et al. · Blood · 2008 · 624 citations · Full text

Life Sciences, Immunology, Oncology +15

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)

Pedro Farinha, Hamid Masoudi, Brian Skinnider et al. · Blood · 2005 · 456 citations

Medicine, Immunology, Oncology +16

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)

Lindsay M. Morton, Jennifer Turner, James R. Cerhan et al. · Blood · 2007 · 389 citations · Full text

Veterinary Medicine, Oncology, Pathology +17

Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium

Nathaniel Rothman, Christine F. Skibola, Sophia Wang et al. · The Lancet Oncology · 2005 · 380 citations

Life Sciences, Genetics, Immunology +16